BRCA Mutations Increase Fertility in Families at Hereditary Breast/Ovarian Cancer Risk.
Deleterious mutations in the BRCA genes are responsible for a small, but significant, proportion of breast and ovarian cancers (5 - 10 %). Proof of de novo mutations in hereditary breast/ovarian cancer (HBOC) families is rare, in contrast to founder mutations, thousands of years old, that may be car...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4457526?pdf=render |
| _version_ | 1819108356310171648 |
|---|---|
| author | Fabrice Kwiatkowski Marie Arbre Yannick Bidet Claire Laquet Nancy Uhrhammer Yves-Jean Bignon |
| author_facet | Fabrice Kwiatkowski Marie Arbre Yannick Bidet Claire Laquet Nancy Uhrhammer Yves-Jean Bignon |
| author_sort | Fabrice Kwiatkowski |
| collection | DOAJ |
| description | Deleterious mutations in the BRCA genes are responsible for a small, but significant, proportion of breast and ovarian cancers (5 - 10 %). Proof of de novo mutations in hereditary breast/ovarian cancer (HBOC) families is rare, in contrast to founder mutations, thousands of years old, that may be carried by as much as 1 % of a population. Thus, if mutations favoring cancer survive selection pressure through time, they must provide advantages that compensate for the loss of life expectancy.This hypothesis was tested within 2,150 HBOC families encompassing 96,325 individuals. Parameters included counts of breast/ovarian cancer, age at diagnosis, male breast cancer and other cancer locations. As expected, well-known clinical parameters discriminated between BRCA-mutated families and others: young age at breast cancer, ovarian cancer, pancreatic cancer and male breast cancer. The major fertility differences concerned men in BRCA-mutated families: they had lower first and mean age at paternity, and fewer remained childless. For women in BRCA families, the miscarriage rate was lower. In a logistic regression including clinical factors, the different miscarriage rate and men's mean age at paternity remained significant.Fertility advantages were confirmed in a subgroup of 746 BRCA mutation carriers and 483 non-carriers from BRCA mutated families. In particular, female carriers were less often nulliparous (9.1 % of carriers versus 16.0 %, p = 0.003) and had more children (1.8 ± 1.4 SD versus 1.5 ± 1.3, p = 0.002) as well as male carriers (1.7 ± 1.3 versus 1.4 ± 1.3, p = 0.024).Although BRCA mutations shorten the reproductive period due to cancer mortality, they compensate by improving fertility both in male and female carriers. |
| first_indexed | 2024-12-22T03:08:38Z |
| format | Article |
| id | doaj.art-8042e41175134988b41636c57698e3e5 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-22T03:08:38Z |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-8042e41175134988b41636c57698e3e52022-12-21T18:40:59ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01106e012736310.1371/journal.pone.0127363BRCA Mutations Increase Fertility in Families at Hereditary Breast/Ovarian Cancer Risk.Fabrice KwiatkowskiMarie ArbreYannick BidetClaire LaquetNancy UhrhammerYves-Jean BignonDeleterious mutations in the BRCA genes are responsible for a small, but significant, proportion of breast and ovarian cancers (5 - 10 %). Proof of de novo mutations in hereditary breast/ovarian cancer (HBOC) families is rare, in contrast to founder mutations, thousands of years old, that may be carried by as much as 1 % of a population. Thus, if mutations favoring cancer survive selection pressure through time, they must provide advantages that compensate for the loss of life expectancy.This hypothesis was tested within 2,150 HBOC families encompassing 96,325 individuals. Parameters included counts of breast/ovarian cancer, age at diagnosis, male breast cancer and other cancer locations. As expected, well-known clinical parameters discriminated between BRCA-mutated families and others: young age at breast cancer, ovarian cancer, pancreatic cancer and male breast cancer. The major fertility differences concerned men in BRCA-mutated families: they had lower first and mean age at paternity, and fewer remained childless. For women in BRCA families, the miscarriage rate was lower. In a logistic regression including clinical factors, the different miscarriage rate and men's mean age at paternity remained significant.Fertility advantages were confirmed in a subgroup of 746 BRCA mutation carriers and 483 non-carriers from BRCA mutated families. In particular, female carriers were less often nulliparous (9.1 % of carriers versus 16.0 %, p = 0.003) and had more children (1.8 ± 1.4 SD versus 1.5 ± 1.3, p = 0.002) as well as male carriers (1.7 ± 1.3 versus 1.4 ± 1.3, p = 0.024).Although BRCA mutations shorten the reproductive period due to cancer mortality, they compensate by improving fertility both in male and female carriers.http://europepmc.org/articles/PMC4457526?pdf=render |
| spellingShingle | Fabrice Kwiatkowski Marie Arbre Yannick Bidet Claire Laquet Nancy Uhrhammer Yves-Jean Bignon BRCA Mutations Increase Fertility in Families at Hereditary Breast/Ovarian Cancer Risk. PLoS ONE |
| title | BRCA Mutations Increase Fertility in Families at Hereditary Breast/Ovarian Cancer Risk. |
| title_full | BRCA Mutations Increase Fertility in Families at Hereditary Breast/Ovarian Cancer Risk. |
| title_fullStr | BRCA Mutations Increase Fertility in Families at Hereditary Breast/Ovarian Cancer Risk. |
| title_full_unstemmed | BRCA Mutations Increase Fertility in Families at Hereditary Breast/Ovarian Cancer Risk. |
| title_short | BRCA Mutations Increase Fertility in Families at Hereditary Breast/Ovarian Cancer Risk. |
| title_sort | brca mutations increase fertility in families at hereditary breast ovarian cancer risk |
| url | http://europepmc.org/articles/PMC4457526?pdf=render |
| work_keys_str_mv | AT fabricekwiatkowski brcamutationsincreasefertilityinfamiliesathereditarybreastovariancancerrisk AT mariearbre brcamutationsincreasefertilityinfamiliesathereditarybreastovariancancerrisk AT yannickbidet brcamutationsincreasefertilityinfamiliesathereditarybreastovariancancerrisk AT clairelaquet brcamutationsincreasefertilityinfamiliesathereditarybreastovariancancerrisk AT nancyuhrhammer brcamutationsincreasefertilityinfamiliesathereditarybreastovariancancerrisk AT yvesjeanbignon brcamutationsincreasefertilityinfamiliesathereditarybreastovariancancerrisk |